2025
New instrument for effective detection of a history of COPD exacerbations, including usually unreported events
ZATLOUKAL, Jaromir; Eva VOLAKOVA; Jana KOVACIKOVA; Martina KULIROVA; Miroslav MARUSCAK et al.Základní údaje
Originální název
New instrument for effective detection of a history of COPD exacerbations, including usually unreported events
Autoři
ZATLOUKAL, Jaromir; Eva VOLAKOVA; Jana KOVACIKOVA; Martina KULIROVA; Miroslav MARUSCAK; Blanka HYTYCHOVA a Vladimir KOBLIZEK
Vydání
Frontiers in Medicine, LAUSANNE, FRONTIERS MEDIA SA, 2025, 2296-858X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.000 v roce 2024
Organizační jednotka
CZECRIN IV
UT WoS
001586753800001
Klíčová slova česky
obstructive lung disease; structured checklist; questionnaire; flare-up; disease history; dyspnea; cough
Klíčová slova anglicky
obstructive lung disease; structured checklist; questionnaire; flare-up; disease history; dyspnea; cough
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 22. 1. 2026 09:56, Bc. Hana Vladíková, BBA
Anotace
V originále
Background: COPD exacerbations are important events for disease management. The incidence of exacerbations impacts prognosis, guides treatment, and predicts future exacerbations. Despite their importance, exacerbations are often underdiagnosed and underreported. The aim of our study was to test and evaluate the effectiveness of a structured checklist for detecting past exacerbations that we developed and that would be suitable for routine clinical practice. Methods: 350 patients with COPD and FEV1 < 80% of the predicted value were enrolled in 35 centers. Each patient completed a structured checklist and underwent an interview with the physician. The number of exacerbations, their symptoms and duration, and the treatments were evaluated. Clinical data on exacerbations in the previous 12 months were retrieved from the patient's medical records and analyzed retrospectively. The data obtained using the structured checklist were compared with the data from the interviews and medical records. Results: Compared to the patient-physician interview, the structured checklist detected more exacerbations since the previous visit (p = 0.025). The difference was significant also for severe exacerbations (p = 0.003). In patients reporting only one event, the structured checklist was more sensitive in detecting mild events than the interview (p < 0.001). The structured checklist detected mild exacerbations in 10 patients in whom the interview detected none. Compared to the number of exacerbations in the medical records, the structured checklist detected more than twice as many events. The mean duration of an exacerbation was 9.7 days, and the most prominent symptoms were dyspnea and productive cough. Conclusion: Proposed structured checklist improved the detection of past exacerbations, including usually unreported events. Moreover, the structured checklist allows the severity and other clinical characteristics of past exacerbations to be specified and used to direct further COPD therapy.
Návaznosti
| 90249, velká výzkumná infrastruktura |
|